Filing Details

Accession Number:
0001209191-10-039277
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-21 13:00:00
Reporting Period:
2010-07-19
Filing Date:
2010-07-21
Accepted Time:
2010-07-21 18:56:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1390478 Rxi Pharmaceuticals Corp RXII Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1460224 Ramani Varanasi C/O Rxi Pharmaceuticals Corporation
60 Prescott Street
Worcester MA 01605
Vp Business Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-07-19 5,000 $2.05 5,558 No 4 S Direct
Common Stock Acquisiton 2010-07-19 5,600 $2.04 11,158 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Footnotes
  1. The sale price reported in this Form 4 was between the range of $2.05 per share and $2.05432 per share. Full information regarding the number of shares sold at each seperate price will be provided to the Commission staff upon request.